DiaSorin Investor Relations Material
Latest events
Q1 2025
DiaSorin
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from DiaSorin S.p.A.
Access all reports
DiaSorin S.p.A. develops and manufactures diagnostic tests and systems for use in clinical laboratories. The company provides immunodiagnostic and molecular diagnostic solutions for detecting infectious diseases, hormones, and oncology markers. It serves healthcare providers and laboratories worldwide. The company is headquartered in Saluggia, Italy, and its shares are listed on the BIT.
Key slides for DiaSorin S.p.A.
Q4 2024
DiaSorin S.p.A.
Q1 2025
DiaSorin S.p.A.
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
DIA
Country
🇮🇹 Italy